HPC Biosciences Ltd vs HINDUSTAN UNILEVER LTD.

A side-by-side comparison of HPC Biosciences Ltd (349945) and HINDUSTAN UNILEVER LTD. (HINDUNILVR) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, HINDUSTAN UNILEVER LTD. leads 349945 vs HINDUNILVR on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth02
  • Size & financial health13

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
31.02
0.00
P/B ratio
10.55
0.00%
Dividend yield
2.04%
₹0.00
EPS
₹64.01

Profitability

HINDUNILVR takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

0.06%
Return on equity
31.00%
0.09%
Return on capital
28.00%
-9.52%
EBITDA margin
23.00%
9.52%
Net margin
23.36%

Growth

HINDUNILVR takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-44.07%
Revenue CAGR (3Y)
2.10%
-61.11%
Profit CAGR (3Y)
14.08%

Size & financial health

HINDUNILVR takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹4.64L Cr
₹0 Cr
Revenue
₹64,468 Cr
₹0 Cr
Net profit
₹15,059 Cr
0.00
Debt / equity
0.03
HPC Biosciences Ltd
  • + ["Company is almost debt free."]
  • ["Stock is trading at 12.8 times its book value", "The company has delivered a poor sales growth of -35.9% over past five years.", "Company has a low return on equity of 0.72% over last 3 years.", "Company has high debtors of 9,907 days.", "Working capital days have increased from 22,169 days to 44,113 days"]
HINDUSTAN UNILEVER LTD.
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 92.4%"]
  • ["Stock is trading at 9.69 times its book value", "The company has delivered a poor sales growth of 6.51% over past five years.", "Earnings include an other income of Rs.4,933 Cr."]
HPC Biosciences Ltd full analysis HINDUSTAN UNILEVER LTD. full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

349945 vs HINDUNILVR: Share Price, Valuation & Which to Buy | DocStoX